Welcome to Invasive Candidiasis in cancer patients Post-Activity Assessment
Thank you and congratulations for attending this educational activity. Remember, continuous professional development is key to success and professional excellence.
This pre test is composed of 9 questions based on the information provided to you during the activity.
Pre-Activity Assessment- Invasive Candidiasis in cancer patients
0 of 9 Questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 9 Questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Kindly fill the post assessment to claim your certificate.
Question 1 of 9
Which of the following drugs can be given to an echinocandin-resistant patient?
Question 2 of 9
Which of the following statements about treatment recommendations for invasive candidiasis in neutropenic patients is correct?
Question 3 of 9
In which of the following clinical scenarios would you start Candida prophylaxis?
Question 4 of 9
Which one of the following statements about the oral bioavailability and absorption of voriconazole is true?
Question 5 of 9
Amphotericin B can be administered in :
Question 6 of 9
The incidence of invasive candidiasis cases is decreasing at the state of Qatar?
Question 7 of 9
Which of the following statements about invasive candidiasis is correct?
Question 8 of 9
Which of the following is the most important barrier to the optimal management of invasive candidiasis in cancer patients?
Question 9 of 9
Which of the following statements best explain the mechanism of antifungal action of Amphotericin B?